1 |
Holtzman AL, Glassman GE, Dagan R, Rao D, Fiester PJ, Tavanaieour D, Morris CG, Indelicato DJ, Mendenhall WM. Long-term outcomes of fractionated proton beam therapy for benign or radiographic intracranial meningioma. J Neurooncol 2023. [PMID: 36692832 DOI: 10.1007/s11060-022-04207-0] [Reference Citation Analysis]
|
2 |
Giammattei L, Passeri T, di Russo P, Froelich S. Anterolateral (juxtacondylar) approach with limited mastoidectomy to resect a jugular foramen meningioma. Acta Neurochir (Wien) 2023. [PMID: 36609565 DOI: 10.1007/s00701-022-05482-6] [Reference Citation Analysis]
|
3 |
Hopper A, Salans M, Karunamuni R, Hattangadi-gluth JA. Neurocognitive considerations in the treatment of meningioma with radiation therapy: applications for quantitative neuroimaging and precision radiation medicine. J Neurooncol 2022. [DOI: 10.1007/s11060-022-04175-5] [Reference Citation Analysis]
|
4 |
Smith‐cohn MA, Gilbert MR. Primary Neoplasms of the Brain in Adults. Holland‐Frei Cancer Medicine 2022. [DOI: 10.1002/9781119000822.hfcm078.pub2] [Reference Citation Analysis]
|
5 |
Vinakurau S, Emmerová R. Proton therapy in the treatment of meningiomas. Onkologie 2022;16:254-257. [DOI: 10.36290/xon.2022.048] [Reference Citation Analysis]
|
6 |
Carlos-Escalante JA, Paz-López ÁA, Cacho-Díaz B, Pacheco-Cuellar G, Reyes-Soto G, Wegman-Ostrosky T. Primary Benign Tumors of the Spinal Canal. World Neurosurg 2022;164:178-98. [PMID: 35552036 DOI: 10.1016/j.wneu.2022.04.135] [Reference Citation Analysis]
|